A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior

Neuron

Volumn 86, Issue 4, 2015, Pages 936-946

  Vardy, Eyal ^a   Robinson, J Elliott ^a   Li, Chia ^b,c   Olsen, Reid H J ^a   DiBerto, Jeffrey F ^a   Giguere, Patrick M ^a   Sassano, Flori M ^a   Huang, Xi Ping ^a   Zhu, Hu ^a   Urban, Daniel J ^a   White, Kate L ^a   Rittiner, Joseph E ^a   Crowley, Nicole A ^a   Pleil, Kristen E ^a   Mazzone, Christopher M ^a   Mosier, Philip D ^d   Song, Juan ^a   Kash, Thomas L ^a   Malanga, C J ^a   Krashes, Michael J ^b,c   Roth, Bryan L ^a   more..

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIGNER RECEPTORS EXCLUSIVELY ACTIVATED BY DESIGNER DRUG; DYNORPHIN A; G PROTEIN COUPLED RECEPTOR; KAPPA OPIATE RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR AFFECTING AGENT; PHEROMONE; SALVINORIN A; SALVINORIN B; UNCLASSIFIED DRUG; DITERPENE; LIGAND;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BEHAVIOR; BIOENGINEERING; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CRYSTALLOGRAPHY; DRUG PENETRATION; FACILITATION; FEMALE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIGAND BINDING; MALE; MOLECULAR EVOLUTION; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DRUG EFFECTS; METABOLISM; NERVE CELL;

ANIMALS; BEHAVIOR, ANIMAL; DITERPENES; LIGANDS; MICE, INBRED C57BL; NEURONS; RECEPTORS, OPIOID, KAPPA; SIGNAL TRANSDUCTION;

EID: 84930244375     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.03.065     Document Type: Article

References (47)

1. Agulhon C., Boyt K.M., Xie A.X., Friocourt F., Roth B.L., McCarthy K.D. Modulation of the autonomic nervous system and behaviour by acute glial cell Gq protein-coupled receptor activation invivo. J.Physiol. 2013, 591:5599-5609.
2. Alexander G.M., Rogan S.C., Abbas A.I., Armbruster B.N., Pei Y., Allen J.A., Nonneman R.J., Hartmann J., Moy S.S., Nicolelis M.A., et al. Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 2009, 63:27-39.
3. Ansonoff M.A., Zhang J., Czyzyk T., Rothman R.B., Stewart J., Xu H., Zjwiony J., Siebert D.J., Yang F., Roth B.L., Pintar J.E. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice. J.Pharmacol. Exp. Ther. 2006, 318:641-648.
4. Aponte Y., Atasoy D., Sternson S.M. AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training. Nat. Neurosci. 2011, 14:351-355.
5. Armbruster B.N., Li X., Pausch M.H., Herlitze S., Roth B.L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. USA 2007, 104:5163-5168.
6. Atasoy D., Betley J.N., Su H.H., Sternson S.M. Deconstruction of a neural circuit for hunger. Nature 2012, 488:172-177.
7. Balthasar N., Dalgaard L.T., Lee C.E., Yu J., Funahashi H., Williams T., Ferreira M., Tang V., McGovern R.A., Kenny C.D., et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 2005, 123:493-505.
8. Besnard J., Ruda G.F., Setola V., Abecassis K., Rodriguiz R.M., Huang X.P., Norval S., Sassano M.F., Shin A.I., Webster L.A., et al. Automated design of ligands to polypharmacological profiles. Nature 2012, 492:215-220.
9. Betley J.N., Cao Z.F., Ritola K.D., Sternson S.M. Parallel, redundant circuit organization for homeostatic control of feeding behavior. Cell 2013, 155:1337-1350.
10. Boyden E.S., Zhang F., Bamberg E., Nagel G., Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 2005, 8:1263-1268.
11. Conklin B.R., Hsiao E.C., Claeysen S., Dumuis A., Srinivasan S., Forsayeth J.R., Guettier J.M., Chang W.C., Pei Y., McCarthy K.D., et al. Engineering GPCR signaling pathways with RASSLs. Nat. Methods 2008, 5:673-678.
12. Deisseroth K. Optogenetics. Nat. Methods 2011, 8:26-29.
13. Dell'Anno M.T., Caiazzo M., Leo D., Dvoretskova E., Medrihan L., Colasante G., Giannelli S., Theka I., Russo G., Mus L., et al. Remote control of induced dopaminergic neurons in parkinsonian rats. J.Clin. Invest. 2014, 124:3215-3229.
14. Dong S., Rogan S.C., Roth B.L. Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs. Nat. Protoc. 2010, 5:561-573.
15. Erlenbach I., Kostenis E., Schmidt C., Hamdan F.F., Pausch M.H., Wess J. Functional expression of M(1), M(3) and M(5) muscarinic acetylcholine receptors in yeast. J.Neurochem. 2001, 77:1327-1337.
16. Fenalti G., Giguere P.M., Katritch V., Huang X.P., Thompson A.A., Cherezov V., Roth B.L., Stevens R.C. Molecular control of δ-opioid receptor signalling. Nature 2014, 506:191-196.
17. Fenalti G., Zatsepin N.A., Betti C., Giguere P., Han G.W., Ishchenko A., Liu W., Guillemyn K., Zhang H., James D., et al. Structural basis for bifunctional peptide recognition at human δ-opioid receptor. Nat. Struct. Mol. Biol. 2015, 22:265-268.
18. Guettier J.M., Gautam D., Scarselli M., Ruiz de Azua I., Li J.H., Rosemond E., Ma X., Gonzalez F.J., Armbruster B.N., Lu H., et al. A chemical-genetic approach to study G protein regulation of beta cell function invivo. Proc. Natl. Acad. Sci. USA 2009, 106:19197-19202.
19. Hooker J.M., Munro T.A., Béguin C., Alexoff D., Shea C., Xu Y., Cohen B.M. Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence. Neuropharmacology 2009, 57:386-391.
20. Jain S., Ruiz de Azua I., Lu H., White M.F., Guettier J.M., Wess J. Chronic activation of a designer G(q)-coupled receptor improves β cell function. J.Clin. Invest. 2013, 123:1750-1762.
21. Kane B.E., Nieto M.J., McCurdy C.R., Ferguson D.M. A unique binding epitope for salvinorin A, a non-nitrogenous kappa opioid receptor agonist. FEBS J. 2006, 273:1966-1974.
22. Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., Jensen N.H., Kuijer M.B., Matos R.C., Tran T.B., et al. Predicting new molecular targets for known drugs. Nature 2009, 462:175-181.
23. Krashes M.J., Koda S., Ye C., Rogan S.C., Adams A.C., Cusher D.S., Maratos-Flier E., Roth B.L., Lowell B.B. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J.Clin. Invest. 2011, 121:1424-1428.
24. Krashes M.J., Shah B.P., Madara J.C., Olson D.P., Strochlic D.E., Garfield A.S., Vong L., Pei H., Watabe-Uchida M., Uchida N., et al. An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature 2014, 507:238-242.
25. Larson D.L., Jones R.M., Hjorth S.A., Schwartz T.W., Portoghese P.S. Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists. J.Med. Chem. 2000, 43:1573-1576.
26. Li J.H., Jain S., McMillin S.M., Cui Y., Gautam D., Sakamoto W., Lu H., Jou W., McGuinness O.P., Gavrilova O., Wess J. A novel experimental strategy to assess the metabolic effects of selective activation of a G(q)-coupled receptor in hepatocytes invivo. Endocrinology 2013, 154:3539-3551.
27. Magnus C.J., Lee P.H., Atasoy D., Su H.H., Looger L.L., Sternson S.M. Chemical and genetic engineering of selective ion channel-ligand interactions. Science 2011, 333:1292-1296.
28. Mahler S.V., Vazey E.M., Beckley J.T., Keistler C.R., McGlinchey E.M., Kaufling J., Wilson S.P., Deisseroth K., Woodward J.J., Aston-Jones G. Designer receptors show role for ventral pallidum input to ventral tegmental area in cocaine seeking. Nat. Neurosci. 2014, 17:577-585.
29. Nakajima K., Wess J. Design and functional characterization of a novel, arrestin-biased designer G protein-coupled receptor. Mol. Pharmacol. 2012, 82:575-582.
30. Noble B., Kallal L.A., Pausch M.H., Benovic J.L. Development of a yeast bioassay to characterize G protein-coupled receptor kinases. Identification of an NH2-terminal region essential for receptor phosphorylation. J.Biol. Chem. 2003, 278:47466-47476.
31. Portoghese P.S. Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol. Sci. 1989, 10:230-235.
32. Robinson J.E., Fish E.W., Krouse M.C., Thorsell A., Heilig M., Malanga C.J. Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism. Psychopharmacology (Berl.) 2012, 220:215-224.
33. Rogan S.C., Roth B.L. Remote control of neuronal signaling. Pharmacol. Rev. 2011, 63:291-315.
34. Roth B.L., Baner K., Westkaemper R., Siebert D., Rice K.C., Steinberg S., Ernsberger P., Rothman R.B. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc. Natl. Acad. Sci. USA 2002, 99:11934-11939.
35. Stachniak T.J., Ghosh A., Sternson S.M. Chemogenetic synaptic silencing of neural circuits localizes a hypothalamus→midbrain pathway for feeding behavior. Neuron 2014, 82:797-808.
36. Sternson S.M., Roth B.L. Chemogenetic tools to interrogate brain functions. Annu. Rev. Neurosci. 2014, 37:387-407.
37. Strader C.D., Gaffney T., Sugg E.E., Candelore M.R., Keys R., Patchett A.A., Dixon R.A. Allele-specific activation of genetically engineered receptors. J.Biol. Chem. 1991, 266:5-8.
38. Todtenkopf M.S., Marcus J.F., Portoghese P.S., Carlezon W.A. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berl.) 2004, 172:463-470.
39. Tong Q., Ye C.P., Jones J.E., Elmquist J.K., Lowell B.B. Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance. Nat. Neurosci. 2008, 11:998-1000.
40. Urban D.J., Roth B.L. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu. Rev. Pharmacol. Toxicol. 2015, 55:399-417.
41. van Zessen R., Phillips J.L., Budygin E.A., Stuber G.D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 2012, 73:1184-1194.
42. Vaqué J.P., Dorsam R.T., Feng X., Iglesias-Bartolome R., Forsthoefel D.J., Chen Q., Debant A., Seeger M.A., Ksander B.R., Teramoto H., Gutkind J.S. A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors. Mol. Cell 2013, 49:94-108.
43. Vardy E., Mosier P.D., Frankowski K.J., Wu H., Katritch V., Westkaemper R.B., Aubé J., Stevens R.C., Roth B.L. Chemotype-selective modes of action of κ-opioid receptor agonists. J.Biol. Chem. 2013, 288:34470-34483.
44. White K.L., Robinson J.E., Zhu H., DiBerto J.F., Polepally P.R., Zjawiony J.K., Nichols D.E., Malanga C.J., Roth B.L. The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities invivo. J.Pharmacol. Exp. Ther. 2015, 352:98-109.
45. Wu H., Wacker D., Mileni M., Katritch V., Han G.W., Vardy E., Liu W., Thompson A.A., Huang X.P., Carroll F.I., et al. Structure of the human κ-opioid receptor in complex with JDTic. Nature 2012, 485:327-332.
46. Yagi H., Tan W., Dillenburg-Pilla P., Armando S., Amornphimoltham P., Simaan M., Weigert R., Molinolo A.A., Bouvier M., Gutkind J.S. A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells. Sci. Signal. 2011, 4:ra60.
47. Zhu H., Pleil K.E., Urban D.J., Moy S.S., Kash T.L., Roth B.L. Chemogenetic inactivation of ventral hippocampal glutamatergic neurons disrupts consolidation of contextual fear memory. Neuropsychopharmacology 2014, 39:1880-1892.